Unknown

Dataset Information

0

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.


ABSTRACT: Curative responses in the treatment of multiple myeloma (MM) are limited by the emergence of therapeutic resistance. To address this problem, we set out to identify druggable mechanisms that convey resistance to proteasome inhibitors (PIs; e.g., bortezomib), which are cornerstone agents in the treatment of MM. In isogenic pairs of PI sensitive and resistant cells, we observed stark differences in cellular bioenergetics between the divergent phenotypes. PI resistant cells exhibited increased mitochondrial respiration driven by glutamine as the principle fuel source. To target glutamine-induced respiration in PI resistant cells, we utilized the glutaminase-1 inhibitor, CB-839. CB-839 inhibited mitochondrial respiration and was more cytotoxic in PI resistant cells as a single agent. Furthermore, we found that CB-839 synergistically enhanced the activity of multiple PIs with the most dramatic synergy being observed with carfilzomib (Crflz), which was confirmed in a panel of genetically diverse PI sensitive and resistant MM cells. Mechanistically, CB-839 enhanced Crflz-induced ER stress and apoptosis, characterized by a robust induction of ATF4 and CHOP and the activation of caspases. Our findings suggest that the acquisition of PI resistance involves adaptations in cellular bioenergetics, supporting the combination of CB-839 with Crflz for the treatment of refractory MM.

SUBMITTER: Thompson RM 

PROVIDER: S-EPMC5482623 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


Curative responses in the treatment of multiple myeloma (MM) are limited by the emergence of therapeutic resistance. To address this problem, we set out to identify druggable mechanisms that convey resistance to proteasome inhibitors (PIs; e.g., bortezomib), which are cornerstone agents in the treatment of MM. In isogenic pairs of PI sensitive and resistant cells, we observed stark differences in cellular bioenergetics between the divergent phenotypes. PI resistant cells exhibited increased mito  ...[more]

Similar Datasets

| S-EPMC6622448 | biostudies-literature
| S-EPMC7933078 | biostudies-literature
| S-EPMC7704934 | biostudies-literature
| S-EPMC7642187 | biostudies-literature
| S-EPMC10203524 | biostudies-literature
2016-10-09 | GSE62237 | GEO
2016-09-13 | GSE78069 | GEO
| S-EPMC7897292 | biostudies-literature
| S-EPMC5363603 | biostudies-literature
2024-06-07 | PXD045439 | Pride